Introduction {#Sec1}
============

Coronary angiography provides an assessment of stenosis severity by visualizing the opacified arterial lumen. However, assessment of stenosis severity in percent diameter correlates poorly with its physiological significance \[[@CR1], [@CR2]\]. Pressure-wire measurement of fractional flow reserve (FFR) has been shown to be reliable in discerning stenoses responsible for inducible ischemia \[[@CR3], [@CR4]\]. Pressure-derived measurement of FFR has aided in identifying clinically relevant stenoses and evaluating the effectiveness of revascularizations \[[@CR5]--[@CR8]\].

Quantification of FFR using angiographic images would be a valuable tool in the cardiac catheterization laboratory, because coronary angiography would then provide both anatomical and physiological assessment of a stenosis. This would eliminate the need to advance a pressure wire across a stenotic lesion, and reduce the cost and time of the procedure. Furthermore, it will provide the opportunity to measure FFR for any lesion in the coronary arteries using only diagnostic angiographic image data. FFR is defined as the ratio of the maximum blood flow in the diseased artery to the hypothetical normal maximum blood flow in the same artery. Hyperemic coronary blood flow could be measured with angiography. Previous densitometric techniques for measuring coronary blood flow have been hampered by physical and physiological limitations. The major limitations include the non-linearity caused by physical degradation factors (such as X-ray scatter and veiling glare) and the inability to measure blood iodine concentration. However, more recent studies have addressed these limitations \[[@CR9]\] by correcting for scatter and veiling glare and by power injection of known iodine concentration in the coronary arterial tree \[[@CR10], [@CR11]\]. The technique for measuring absolute volumetric coronary blood flow has previously been validated using flow probes \[[@CR10]--[@CR13]\].

The challenge in determining FFR lies in quantifying the hypothetical normal maximum blood flow in an already diseased artery. Recent studies have shown that the maximum flow through any point in the epicardial coronary arterial tree is related to the sum of its distal coronary arterial lumen volume \[[@CR14]--[@CR18]\]. Based on these studies, coronary arterial volume can be used to estimate the normal maximum blood flow. A previous study has validated an angiographic method for measuring lumen volume \[[@CR19]\]. Therefore, FFR could be measured using angiographic images, acquired at maximum hyperemia, by quantifying both the coronary blood flow and arterial lumen volume.

The aim of this study was to determine the correlation between FFR measured with angiographic image data and FFR based on pressure-wire. A swine model was used to test the hypothesis that angiographically measured FFR is strongly correlated with pressure-derived FFR. This is the first effort to quantify FFR with angiographic image data in an in vivo model. The determination of FFR with angiography can provide valuable physiological, as well as anatomical, information about a stenosis during routine diagnostic cardiac catheterization.

Methods {#Sec2}
=======

In vivo swine model {#Sec3}
-------------------

A closed-chest swine model was used to measure FFR for various levels of stenosis severities in the left anterior descending (LAD) artery. For each stenosis, a set of pressure recordings and coronary angiograms were acquired. The study protocol was approved by the University of California, Irvine Institutional Animal Care and Use Committee.

Fasted swine (Yorkshire, 25--35 kg, *N* = 10) were sedated and pre-medicated with xylazine (2.0 mg/kg), ketamine (10 mg/kg), and atropine (0.05 mg/kg). Anesthesia was maintained with approximately 1--2% isoflurane (Highland Medical Equipment Vaporizer; Temecula, CA). Heart rate and percent oxygen saturation were continuously measured (Nellcor N-200 Pulse Oximeter; Hayward, CA). Arterial partial pressure of CO~2~ was maintained within normal limits (40--45 mmHg). Expired partial pressure of CO~2~ was continuously monitored with a CO~2~ monitor (Ohmeda 5200, Ohmeda, Liberty Corner, NJ), while arterial partial pressure of CO~2~ was periodically determined via arterial blood gas measurements. Carotid artery and jugular vein cut-downs were employed for sheath placement. Prior to catheterization, heparin was given (10,000 units bolus followed by additional 4,000--5,000 units/h). The left main ostium was cannulated with a 6F or 7F hockey-stick catheter through the left carotid artery under fluoroscopic guidance. Electrocardiogram, arterial blood pressure, and distal coronary blood pressure were continuously measured with the ComboMap (Volcano Corp; Rancho Cordova, CA). All signals measured by the ComboMap along with the X-ray pulse signal were continuously recorded and analyzed post-study with AcqKnowledge (Biopac Systems, Inc.; Santa Barbara, CA). An example of the recorded signals during resting and hyperemic flows is shown in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Continuous recording of pressures, flow velocity, and X-ray signal during (*left*) resting and (*right*) hyperemic flow

Each swine was positioned on its right side under a flat panel detector. The projection angle was optimized for the separation of the LAD and left circumflex artery perfusion beds as performed during diagnostic cardiac catheterization. Unavoidable overlap of small branches can contribute to the error in flow and volume calculation, but these errors are small relative to the overall flow and volume. Intracoronary injection of papaverine (5--10 mg) was used for maximum hyperemic induction. Coronary angiograms were acquired within 90 s after intracoronary administration of papaverine. Prior to coronary angiography, pancuronium (0.1 mg/kg) was administered intravenously, and the ventilator was turned off at the end of full expiration to minimize respiratory motion. Contrast material (Omnipaque-350; Princeton, NJ) was power injected (Leibel-Flarsheim Angiomat 6000; Cincinnati, OH) at 4 ml/s. At least a full heart cycle of images was acquired prior to contrast material injection for the selection of a cardiac phase-matched mask image for digital background subtraction. An image of a calibration phantom positioned over the heart was also acquired to determine the correlation between image gray level and iodine mass. The exclusion criterion included respiratory motion. Experimental runs with technical errors such as poor catheter engagement, complete occlusion of any branch, and acquiring angiograms later than 90 s after the administration of papaverine were omitted from the study.

A range of blood flow in normal swine LAD was produced with balloon catheters of different sizes and inflation pressures. Balloon sizes ranged from 2.5 to 3.75 mm in diameter and 8--15 mm in length based on a qualitative visual estimation of each LAD diameter. The coronary balloons were advanced to the proximal LAD over a guide wire under fluoroscopic guidance. The coronary balloons were then inflated to different pressures to produce a range of occlusions and hence different degrees of coronary blood flow reduction. A similar approach has been used previously \[[@CR20]\]. The effect of stenosis severity on flow and pressure were studied. However, the degree of stenosis was not measured because placement of balloons made it difficult to accurately measure percent stenosis. The correlation between FFR and angiographic stenosis has previously been shown to be poor \[[@CR21]\]. Each implemented stenosis was considered to be independent from each other since the purpose of the study was to determine if angiographic FFR provides a good surrogate measure of pressure-wire FFR.

Imaging system {#Sec4}
--------------

All images were acquired using a conventional X-ray tube with a constant potential X-ray generator (Optimus M200, Philips Medical Systems, Shelton, CT). A cesium-iodide-based flat panel detector (PaxScan 4030A, Varian Medical Inc., Palo Alto, CA) was used for image acquisition. The flat panel detector has a 40 × 30 cm^2^ field of view and pixel size of 0.194 × 0.194 mm^2^. The zoom-center mode was used to acquire images with 1,024 × 768 pixels. Gain and flat field corrections were performed prior to image acquisition. The flat panel detector has no pincushion distortion and has a dynamic range greater than 8,000. Images were acquired at 30 frames/s. The detector signal in each pixel was digitized with 14-bit precision. Images were logarithmically transformed before subtraction. A Pentium IV computer and publicly available software Image J (NIH, Bethesda, MD) were used for image analysis.

Angiographic based FFR {#Sec5}
----------------------

Our goal was to measure coronary FFR using only angiographic image data. Coronary FFR is defined as follows:$$\documentclass[12pt]{minimal}
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                \begin{document}$$ {\text{FFR}}_{Q} = {\frac{{Q_{\text{S}} }}{{Q_{\text{N}} }}} $$\end{document}$$where *Q*~S~ is the hyperemic flow through an artery with a stenosis, and *Q*~N~ is the hypothetical normal hyperemic flow through the same artery without disease. A first pass analysis technique to measure coronary blood flow using angiographic image data has previously been validated using flow probe \[[@CR10], [@CR11], [@CR22]\]. Therefore, coronary blood flow in the stenotic artery (*Q*~S~) can be directly measured using this technique. The challenge with calculating FFR is determining the hypothetical normal hyperemic flow in the same artery (*Q*~N~). The dependent myocardial mass is used in positron emission tomography (PET) to estimate the expected normal blood flow. Myocardial mass cannot be estimated using angiography. Previous studies, however, have shown that flow through any point in the epicardial coronary arterial tree is also related to the sum of the distal coronary arterial lumen volume \[[@CR14]--[@CR18]\]. The relationship between flow (*Q*) and the distal arterial lumen volume (*V*) was found to be:$$\documentclass[12pt]{minimal}
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                \begin{document}$$ Q_{\text{N}} = k\left( {{\frac{V}{{V_{\text{ref}} }}}} \right)^{3/4} $$\end{document}$$where *k* is the scaling coefficient relating crown volume to normal maximum hyperemic flow. The scaling coefficient *k* has units of ml/min since *Q*~N~ has units of ml/min and lumen volume was made dimensionless by normalization to a reference volume of *V*~ref~ = 1 ml. By combining Eqs. [1](#Equ1){ref-type=""} and [2](#Equ2){ref-type=""}, FFR can then be calculated using:$$\documentclass[12pt]{minimal}
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                \begin{document}$$ {\text{FFR}}_{V} = {\frac{{Q_{\text{S}} }}{{k\left( {{\frac{V}{{V_{\text{ref}} }}}} \right)^{3/4} }}} $$\end{document}$$The above equation shows that FFR can be measured using *Q*~S~, *V* and *k*. A technique to measure lumen volume using angiographic image data has previously been validated \[[@CR19]\]. Therefore, all of the parameters necessary to calculate coronary FFR can be measured using angiographic image data.

Coronary arterial volume (*V*) was determined using angiographic images acquired during end-diastole after contrast material has propagated throughout the epicardial arteries, but before the opacification of the coronary sinus and termination of power injection. A calibration of the imaging chain for quantifying iodine mass from X-ray densitometric signal was performed by acquiring an image of the calibration phantom over the pig hearts \[[@CR10], [@CR23], [@CR24]\]. The calibration phantom was placed on the chest so that its projection overlapped the heart. Correction was made for differential magnification of the phantom and the heart. Power injection of contrast material was assumed to momentarily replace blood with contrast material. The known iodine concentration in the contrast material and a linear regression analysis between measured gray levels and known iodine masses in the calibration phantom were used to convert gray level to volume. A region-of-interest (ROI) was drawn around visible arteries for volume quantification (see Fig. [2](#Fig2){ref-type="fig"}). Coronary arterial volume was then calculated using densitometry. Gray values were converted to volume measurements with a conversion factor determined from the acquired image of the calibration phantom \[[@CR19]\].Fig. 2An example of a region-of-interest used for angiographic volume determination in epicardial arteries

Coronary blood flow (*Q*~S~) was determined from the change in volume within one cardiac cycle. A global ROI encompassing the visible arteries, as well as the microcirculatory blush, was drawn for flow measurement (see Fig. [3](#Fig3){ref-type="fig"}). Coronary flow was then quantified using a first pass distribution analysis. The first pass distribution analysis assumes that contrast material of a known concentration enters a collection reservoir via a single arterial input and that all measurements are made prior to the contrast material leaving the selected region designated by the ROI. The change in the measured densitometric signal was converted to volume measurement using system iodine calibration. The time period of the cardiac cycle was calculated from the image acquisition rate of 30 frames/s. The ratio of the measured volume change to the time period of the cardiac cycle yields volumetric coronary blood flow \[[@CR10], [@CR11], [@CR22]\].Fig. 3An example of a global region-of-interest (ROI) used for angiographically measured coronary volume flow

The influence of hemodynamic conditions (such as heart rate, mean arterial pressure, contractility, and left ventricular preload) on hyperemic blood flow that is independent of changes in the resistance state of the coronary circulation is known. Previous studies observed that hyperemic blood flow did not change significantly with heart rate \[[@CR25]--[@CR27]\], left ventricular preload \[[@CR25]\], or ventricular contractility \[[@CR26], [@CR28]\]. However, hyperemic blood flow was altered proportionately with arterial pressure \[[@CR25]--[@CR27]\]. In order to address the influence of arterial pressure on hyperemic flow, the scaling coefficient (see Eq. [2](#Equ2){ref-type=""}) was calculated as a function of pressure according to the following:$$\documentclass[12pt]{minimal}
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                \begin{document}$$ k = m\left( {{\frac{{P_{\text{a}} }}{{P_{\text{ref}} }}}} \right) + b $$\end{document}$$where *m* and *b* are the slope and *y*-intercept of the regression line, respectively. The mean aortic pressure *P*~a~ was made unitless by normalizing to a reference pressure *P*~ref~ = 1 mmHg. Thus, both the slope and *y*-intercept parameters have units of ml/min. In order to evaluate the linear correlation in Eq. [4](#Equ4){ref-type=""}, coronary flow, arterial volume, and *P*~a~ during maximum hyperemia in the absence of a stenosis were measured in each pig. The values of *k* were calculated from the measured normal coronary flow and volume, and plotted against *P*~a~. A regression analysis was then performed to determine the values of *m* and *b*. The values for the parameters have been determined to be *m* = 0.99 and *b* = 98.07. Because *k* in Eq. [4](#Equ4){ref-type=""} accounts for the effects of aortic pressure on the relationship between normal maximum hyperemic coronary flow and arterial volume, coronary flow and volume measurements can be used directly to calculate FFR~*V*~ in Eq. [3](#Equ3){ref-type=""}.

Pressure-based FFR {#Sec6}
------------------

Current clinical measurement of FFR is pressure-derived (FFR~*P*~) according to the following expression using aortic pressure (*P*~a~) and the coronary pressure distal to the stenosis (*P*~d~):$$\documentclass[12pt]{minimal}
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                \begin{document}$$ {\text{FFR}}_{P} = {\frac{{P_{\text{d}} }}{{P_{\text{a}} }}} $$\end{document}$$This clinically used term can be further described as a measure of myocardial FFR, which takes into account collateral contribution. Intracoronary measurements of pressure were performed using a ComboWire (ComboWire Model 9515 and 9500, Volcano Corp.; Rancho Cordova, CA). The ComboWire was positioned alongside or within the balloon catheter. When inside the balloon catheter, the maneuverability of the ComboWire was diminished and a substantial drift in the pressure signal was noted when the balloon catheter shaft overrode the pressure sensor. Thus, the ComboWire was advanced so that the pressure sensor was sufficiently distal to the balloon catheter tip and care was taken not to pull the pressure sensor portion of the ComboWire to within the monorail of the balloon. Once the balloon and ComboWire were in place, equalization of pressures was performed with the balloon deflated at resting blood flow. Maximum hyperemia was induced with papaverine. *P*~a~ and *P*~d~ were measured continuously with a pressure transducer and ComboWire, respectively. FFR~*P*~ was calculated from mean pressure values over 5 cardiac cycles just prior to coronary angiography. With contrast material injection lasting for approximately 3 s, the time between FFR~*P*~ and FFR~*V*~ measurements was at most 5 s.

Statistical analysis {#Sec7}
--------------------

Linear regression analysis was performed between FFR~*P*~ and FFR~*V*~ to determine the coefficients in the regression equation: FFR~*P*~ = *m*~r~ FFR~*V*~ + *b*~r~, where *m*~r~ and *b*~r~ are the slope and *y*-intercept of the linear regression line. The significance of the correlation between FFR~*P*~ and FFR~*V*~ was determined, where a value of *P* \< 0.05 was considered to be statistically significant. The correlation coefficient (*r*) and standard error of estimate (SEE) were determined from the linear regression analysis. SEE defines the standard deviation of the measured values from the regression line.

Results {#Sec8}
=======

The hemodynamic data for the study are summarized in Table [1](#Tab1){ref-type="table"}. The mean *P*~a~ was 56.0 ± 10.9 mmHg, and the mean heart rate was 93.1 ± 10.5 beats/min. Injection of papaverine decreased the mean arterial pressure by 26.9 ± 9.7%. The mean FFR~*P*~ and FFR~*V*~ were 0.79 ± 0.12 and 0.66 ± 0.23, respectively. A total of 82 imaging measurements were made from which 11 measurements were excluded from analysis due to respiratory motion.Table 1Hemodynamic data of ten swine experimentsMean*σ*Body weight (kg)314*P*~a~ (mmHg)56.010.9Δ*P* with papaverine (%)26.99.7Heart rate (beats/min)93.110.5Papaverine-angiography time (s)5119FFR~*P*~0.790.12FFR~*V*~0.660.23The mean value and standard deviation (*σ*) of each parameter are given

A comparison of FFR~*V*~ and FFR~*P*~ measurements is given in Fig. [4](#Fig4){ref-type="fig"}. A strong correlation was observed (*r* = 0.85) with SEE = 0.07. The equation of the regression line was determined as FFR~*P*~ = 0.41 FFR~*V*~ + 0.52 (*P*-value \< 0.001). FFR, defined as a ratio of diseased to normal flow (Eq. [1](#Equ1){ref-type=""}), was also quantified since the normal flow through the LAD was known from angiographic flow measurements. This flow-derived FFR (FFR~*Q*~) was calculated in the nine pigs with normal flows that were measurable with angiographic data (Pig 7 was excluded because of respiratory motion). Figure [5](#Fig5){ref-type="fig"} compares the flow-derived FFR (FFR~*Q*~) to FFR~*P*~. The equation of the regression line relating FFR~*Q*~ to FFR~*P*~ was determined as FFR~*P*~ = 0.61 FFR~*Q*~ + 0.52 with a correlation coefficient of 0.87 and SEE of 0.07.Fig. 4A linear regression analysis of FFR~*P*~ and FFR~*V*~ measurements. The *solid line* represents the regression line (FFR~*P*~ = 0.41 FFR~*V*~ + 0.52; *r* = 0.85; SEE = 0.072). Standard errors in the slope and *y*-intercept values are 0.03 and 0.02, respectivelyFig. 5A linear regression analysis of FFR~*P*~ and FFR~*Q*~ measurements. The *solid line* represents the regression line (FFR~*P*~ = 0.61 FFR~*Q*~ + 0.52; *r* = 0.87; SEE = 0.070). Standard errors in the slope and *y*-intercept values are 0.03 and 0.02, respectively

Discussion {#Sec9}
==========

The results of FFR measurements in swine showed a strong linear correlation between the proposed angiographic technique and the clinical pressure-wire method. Figure [4](#Fig4){ref-type="fig"} shows that volume-derived FFR values measured angiographically correlated well with the pressure-derived values measured with a pressure sensor-wire (*r* = 0.85 and SEE = 0.07). These experimental results were similar to previous studies comparing pressure-derived FFR to relative flow reserve (RFR) determined with PET \[[@CR3], [@CR29]\]. RFR was defined as the maximal achievable perfusion in the stenotic region divided by the maximal achievable perfusion in the neighboring region supplied by a normal coronary artery. Under similar microvascular resistances and hemodynamic conditions, RFR should be equivalent to FFR. De Bruyne et al. \[[@CR3]\] showed that pressure-derived myocardial FFR correlated closely with RFR measured with PET, with *r* = 0.87 and SEE = 0.13. Similarly, Marques et al. \[[@CR29]\], in their study of the effects of myocardial infarction on microvascular resistance, found that FFR and RFR correlated well (*r* = 0.81). Their measurements of RFR and FFR showed a mean difference of 0.01 with a standard deviation of 0.11.

Figure [4](#Fig4){ref-type="fig"} shows that FFR~*V*~ underestimated FFR~*P*~ at lower values. A similar underestimation was observed by Pijls et al. \[[@CR30]\] when they compared coronary FFR as defined by a flow ratio to myocardial FFR calculated by a pressure ratio. Pijls et al. argued that the observed difference was due to the inclusion of collateral flow in myocardial FFR but not in coronary FFR, where *y*-intercept values as high as 0.36 were attributed to the abundant collateral circulation in mongrel dogs, but the collateral circulation were not verified with direct measurement. Collateral circulation in swine is known to be negligible; thus, coronary and myocardial FFR should be similar in pigs, but Fig. [4](#Fig4){ref-type="fig"} shows that FFR~*V*~ underestimated FFR~*P*~. An argument against collateral circulation as a substantial source of difference in measured FFR values in the range of clinically applicable perfusion pressures and moderate stenosis levels includes the study by Messina et al. \[[@CR31]\] where differences in flow with and without collateral circulation were only appreciable at low perfusion pressures (\<40 mmHg). This suggested that FFR measured by a flow ratio with and without collateral circulation is similar for perfusion pressures greater than 40 mmHg. Thus, the differences observed by Pijls et al. between coronary and myocardial FFR in dogs cannot be fully attributed to collateral circulation alone. Additionally, when myocardial FFR values based on perfusion measurements were compared to pressure measurements an underestimation of perfusion measurements relative to pressure measurements was observed \[[@CR3]\]. Since the contribution of collateral flow would be included in perfusion measurements, the observed underestimation would not be due to collateral circulation.

Instead, the difference in FFR measurements may be explained by the inherent theoretical differences between the ratio *P*~d~/*P*~a~ and *Q*~S~/*Q*~N~ and the nonlinear relationship between flow and pressure changes. A comparison of FFR~*P*~ and FFR~*V*~ should not be expected to follow the line of identity because the ratio of *P*~d~/*P*~a~ is not equivalent to *Q*~S~/*Q*~N~ if back pressure in terms of wedge pressure is ignored. Wedge pressure can reach as high as 25 mmHg in the absence of any collateral flow. Together with the considerably low mean aortic pressure (*P*~a~ = 56 mmHg) in our animals, the lack of correction for *P*~w~ could introduce significantly large *y*-intercept values.

The observed highly correlated, but non-identical, relationship between FFR~*P*~ and FFR~*V*~ in Fig. [4](#Fig4){ref-type="fig"} is in accordance with flow-pressure relationships. For example, previous studies have shown that the coronary pressure-flow curve is convex rather than linear, where flow drops off more rapidly than pressure at low pressure or flow states \[[@CR32]\]. The observed nonlinearity stems from the compliance or elasticity of coronary vessels as they respond to the decreasing distending pressures distal to the stenosis \[[@CR33]\]. Figure [6](#Fig6){ref-type="fig"} plots the data from Pantely et al. \[[@CR32], [@CR34], [@CR35]\] in the form of pressure- and flow-derived FFR values. The FFR values plotted in Fig. [6](#Fig6){ref-type="fig"} were determined using their raw distal pressure and flow measurements normalized by maximum pressure and flow measurements to reflect *P*~a~ and *Q*~N~ values, respectively. Figure [6](#Fig6){ref-type="fig"} clearly shows the nonlinearly between *P*~d~/*P*~a~ and *Q*~S~/*Q*~N~. The experimentally measured FFR~*P*~ (which is *P*~d~/*P*~a~) and FFR~*Q*~ (which is equivalent to *Q*~S~/*Q*~N~) were also included in Fig. [6](#Fig6){ref-type="fig"} in order to demonstrate that the experimentally observed relationship is consistent with previous flow and pressure results. Figure [6](#Fig6){ref-type="fig"} also shows that the relationship between *P*~d~/*P*~a~ and *Q*~S~/*Q*~N~ is approximately linear for values greater 0.2, which is important since coronary stenoses with FFR values less than 0.2 do not require FFR measurement for intervention. An extrapolation of data in this linear portion would lead to the observed 0.49 *y*-intercept. Previous studies have found similar overestimations of the pressure intercept when considering the same range of pressures and flows \[[@CR32], [@CR34], [@CR35]\].Fig. 6Pooled data showing the relation between simplified myocardial fractional flow reserve (*P*~d~/*P*~a~) and direct flow reserve (*Q*~S~/*Q*~N~) in swine. *Open circles* represent data from the current study where FFR~*P*~ is (*P*~d~/*P*~a~) and FFR~*Q*~ is equivalent to (*Q*~S~/*Q*~N~). *Closed triangles* are extracted from published data by Pantely et al. \[[@CR32], [@CR34], [@CR35]\] where blood flow was measured with Doppler flow probe

In comparing our measured FFR~*Q*~ to FFR~*P*~ we see a slightly higher correlation (*r* = 0.87) than we do for FFR~*V*~. This is expected, since normal hyperemic flow is measured directly rather than estimated from arterial volume. However, the rather small difference in errors between Figs. [4](#Fig4){ref-type="fig"} and [5](#Fig5){ref-type="fig"} suggests that volume-based estimation of normal hyperemic flow adds only limited variability and can be used in the clinical setting, where normal flow through a diseased artery is not available.

Given the limitations of uncorrected pressure-based FFR calculation, future clinical studies might benefit from direct flow measurement of the image-based technique. Ideally, all future comparisons should be referenced to another blood flow modality, potentially PET or flow probe (if done in animals). However, pressure-based comparisons are sufficient if an accurate measure of wedge pressure is available.

Study limitations {#Sec10}
-----------------

Measurement errors associated with angiographic measurements of coronary volume and flow are higher than pressure measurements by sensor-wire. Where pressure measurements are known to be highly reproducible, the variability in volume measurement was approximately 9% and variability in coronary flow was approximately 15% when compared to Doppler sensor-wire measurements of average peak velocity. The reproducibility of FFR~*V*~ was not assessed, but the reproducibility of volume and flow measurements have been previously studied \[[@CR10], [@CR19]\].

Additionally, FFR~*V*~ values can be greater than 1 because the expected flow in absence of a stenosis is estimated based on the measured volume using the equation for the scaling coefficient (see Eq. [3](#Equ3){ref-type=""}). Values greater than 1 are due to measurement error as well as variability in the scaling coefficient *k*. The inherent heterogeneity in *k* can affect the clinical effectiveness of FFR~*V*~ for evaluating stenosis severity. In the current study, a variability of approximately 10% was observed in *k*, which was comparable to previous studies on the heterogeneity in hyperemic perfusion using PET \[[@CR36], [@CR37]\]. Thus, the clinical application of this methodology will require a reassessment of the scaling coefficient expressed in Eq. [4](#Equ4){ref-type=""} as well as a study on the threshold for hemodynamically significant stenoses similar to that validated for FFR~*P*~. A simple estimation using the regression equation shown in Fig. [4](#Fig4){ref-type="fig"} suggests a threshold of approximately FFR~*V*~ = 0.70 for a pre-determined FFR~*P*~ threshold of 0.80, but a validation study will be required in a clinical setting.

In the current study, only coronary angiograms without respiratory motion were analyzed for FFR~*V*~. However, images without respiratory motion cannot always be expected in the clinical setting. Respiratory motion can introduce misregistration artifacts in phase-matched subtracted images and increase measurement error in coronary flow and volume. However, motion misregistration artifacts can be minimized through breath-hold due to the short time interval required for image acquisition (3--5 s), as compared to a previously reported technique that required 15--20 s \[[@CR38]\]. In addition, a technique of using linear interpolation to measure coronary flow and volume signals in unsubtracted images has been developed \[[@CR24]\].

Another limitation of the current study is that only LADs in normal coronary networks from healthy swine were studied. The experimental model only simulated a focal epicardial stenosis. Other disease conditions, such as ventricular hypertrophy, diffuse coronary artery disease, and prior myocardial infarction can potentially introduce disparities between FFR~*V*~ and the level of epicardial stenosis severity. The influence of other disease conditions on FFR~*V*~ requires additional study. Moreover, since only LADs were studied, different results using different coronary territories is potentially possible.

Conclusions {#Sec11}
===========

This study validated a linear relationship between an angiographic FFR and the standard pressure-derived FFR. The application of angiographic FFR in humans would provide a useful method of assessing the physiological severity of a coronary stenosis during diagnostic cardiac catheterization without a need to cross a stenosis with a pressure-wire. Therefore, angiographic images can potentially be used for both anatomical and physiological assessment of coronary artery disease.
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